% alzhub.org library filter
% Source: https://alzhub.org/research?q=lecanemab&category=assessment
% 3 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{mao2026-41520099,
  author  = {Mao, Chenhui and Wang, Wenjun and Huang, Xinying and Wu, Meiqi and Wang, Yifei and Wang, Tianyi and Qiu, Yuyue and Chu, Shanshan and others},
  title   = {{Real world clinical practice of lecanemab at PUMCH dementia cohort: focus on dynamic imaging and biomarker evolution}},
  journal = {Alzheimer s Research \& Therapy},
  year    = {2026},
  doi     = {10.1186/s13195-025-01943-z},
  pmid    = {41520099},
  url     = {https://doi.org/10.1186/s13195-025-01943-z}
}

@article{kang2025-41069006,
  author  = {Kang, Wenyan and Gao, Chao and Li, Xiaoyan and Wang, Xiaoxue and Zhong, Huizhu and Wei, Qiao and Tang, Yonghua and Huang, Peijian and others},
  title   = {{Safety and effectiveness of lecanemab in Chinese patients with early Alzheimer’s disease: Evidence from a multidimensional real-world study}},
  journal = {Chinese Medical Journal},
  year    = {2025},
  doi     = {10.1097/cm9.0000000000003888},
  pmid    = {41069006},
  url     = {https://doi.org/10.1097/cm9.0000000000003888}
}

@article{wang2025-40911712,
  author  = {Wang, Guoqiao and Li, Yan and McDade, Eric and Xiong, Chengjie and Hartz, Sarah M. and Bateman, Randall John and Morris, John C. and Schneider, Lon S. S. and others},
  title   = {{Clinical progression on CDR‐SB©: Progression‐free time at each 0.5 unit level in dominantly inherited and sporadic Alzheimer's disease populations}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz.70643},
  pmid    = {40911712},
  url     = {https://doi.org/10.1002/alz.70643}
}